ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
-1,03%
Bitcoin
62 929,67
6,44%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Collegium Pharmaceutical Inc (COLL)

  7. Collegium Pharmaceutical Inc (COLL) Actualités

COLL Collegium Pharmaceutical Inc

37,475
-0,035 (-0,09%)
Après les heures de négociation
Dernière mise à jour : 23:30:00
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Collegium Pharmaceutical Inc COLL NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,035 -0,09% 37,475 23:30:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
37,80 37,29 38,32 37,475 37,51
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
29/4/202414:00GLOBECollegium Announces Authorized Generic Agreement with Hikma..
25/4/202414:00GLOBECollegium to Report First Quarter 2024 Financial Results on..
11/4/202414:00GLOBECollegium Pharmaceutical, Inc. Announces Redemption of..
03/4/202414:00GLOBECollegium to Participate in 23rd Annual Needham Virtual..
04/3/202422:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202423:24EDGAR2Form 144 - Report of proposed sale of securities
26/2/202422:39EDGAR2Form 144 - Report of proposed sale of securities
22/2/202422:09GLOBECollegium Reports Record Fourth Quarter and Full-Year 2023..
22/2/202422:03EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
22/2/202422:01EDGAR2Form 8-K - Current report
14/2/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202422:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202422:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202422:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202422:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202418:04EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/2/202414:00GLOBECollegium to Report Fourth Quarter and Full-Year 2023..
18/1/202422:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/1/202422:20EDGAR2Form 144 - Report of proposed sale of securities
03/1/202414:03EDGAR2Form 8-K - Current report
03/1/202414:00GLOBECollegium Provides 2024 Financial Guidance
22/12/202322:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202322:15EDGAR2Form 144 - Report of proposed sale of securities
20/12/202323:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202322:28EDGAR2Form 144 - Report of proposed sale of securities
19/12/202322:13EDGAR2Form 144 - Report of proposed sale of securities
18/12/202322:11EDGAR2Form 144 - Report of proposed sale of securities
29/11/202322:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/11/202323:00EDGAR2Form 144 - Report of proposed sale of securities
27/11/202314:00GLOBEAppeals Court Upholds PTAB’s Finding of Invalidity of..
09/11/202314:05EDGAR2Form 8-K - Current report
09/11/202314:00GLOBECollegium Announces $25 Million Accelerated Share Repurchase..
08/11/202314:00GLOBECollegium to Participate in Upcoming Investor Conferences
07/11/202322:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202322:01EDGAR2Form 8-K - Current report
07/11/202322:01GLOBECollegium Reports Third Quarter 2023 Financial Results
24/10/202314:00GLOBECollegium to Report Third Quarter 2023 Financial Results on..
28/8/202314:00GLOBECollegium Announces 10 Poster Presentations at PAINWeek..
24/8/202314:05EDGAR2Form 8-K - Current report
24/8/202314:00GLOBECollegium Announces Extension of Nucynta Regulatory..
10/8/202322:06EDGAR2Form S-8 - Securities to be offered to employees in employee..
07/8/202313:40EDGAR2Form 8-K - Current report
07/8/202313:30GLOBECollegium Announces $50 Million Accelerated Share Repurchase..
03/8/202322:03EDGAR2Form 8-K - Current report
03/8/202322:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/8/202322:01GLOBECollegium Reports Record 1H’23 Net Revenue of $280.3..
20/7/202314:00GLOBECollegium to Report Second Quarter 2023 Financial Results on..
28/6/202322:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/6/202314:00GLOBECollegium to Participate in Jefferies Healthcare Conference
04/5/202322:01GLOBECollegium Reports First Quarter 2023 Financial Results

Dernières Valeurs Consultées

NASDAQ
COLL
Collegium Pharmaceutical
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés